COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 1814: Articles 18131-18140  | Next

Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical Clustering
Di Castelnuovo, A., Gialluisi, A., The COVID-19 RISK and Treatments (CORIST) Collaboration, , Iacoviello, L.
10.1101/2021.01.27.21250238 — Posted: 2021-01-29
Post-Mendelian genetic model in COVID-19
Picchiotti, N., Benetti, E., Fallerini, C., Daga, S., Baldassarri, M., Fava, F., Zguro, K., Valentino, F., Doddato, G., Giliberti, A., Tita, R., Amitrano, S., Bruttini, M., Di Sarno, L., Iuso, N., Alaverdian, D., Beligni, G., Croci, S., Meloni, I., Pinto, A. M., Gabbi, C., Ceri, S., Esposito, A., Pinoli, P., Crawley, F. P., Frullanti, E., Mari, F., GEN-COVID Multicenter Study, , Gori, M., Renieri, A., Furini, S.
10.1101/2021.01.27.21250593 — Posted: 2021-01-29
Spike mutations decrease SARS-CoV-2 sensitivity to neutralizing antibodies but not ACE2-Ig in vitro
Yao, W., Wang, Y., Ma, D., Tang, X., Wang, H., Li, C., Lin, H., Li, Y., Zhong, G.
10.1101/2021.01.27.428353 — Posted: 2021-01-28
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
Dong, J., Zost, S., Greaney, A., Starr, T. N., Dingens, A. S., Chen, E. C., Chen, R., Case, B., Sutton, R., Gilchuk, P., Rodriguez, J., Armstrong, E., Gainza, C., Nargi, R., Binshtein, E., Xie, X., Zhang, X., Shi, P.-Y., Logue, J., Weston, S., McGrath, M., Frieman, M., Brady, T., Tuffy, K., Bright, H., Loo, Y.-M., McvTamney, P., Esser, M., Carnahan, R., Diamond, M., Bloom, J., Crowe, J. E.
10.1101/2021.01.27.428529 — Posted: 2021-01-28
Coronavirus associated molecular mimicry common to SARS-CoV-2 peptide
Adiguzel, Y.
10.1101/2021.01.28.428642 — Posted: 2021-01-28
Modeling mutational effects on biochemical phenotypes using convolutional neural networks: application to SARS-CoV-2
Wang, B., Gamazon, E. R.
10.1101/2021.01.28.428521 — Posted: 2021-01-28
Early therapy with remdesivir and antibody combinations improves COVID-19 disease in mice
Martinez, D., Schaefer, A., Leist, S. R., Gully, K., Feng, J., Bunyan, E., Porter, D., Cihlar, T., Montgomery, S., Baric, R. S., Nussenzweig, M. C., Sheahan, T. P.
10.1101/2021.01.27.428478 — Posted: 2021-01-28
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage
Cheng, Y.-W., Chao, T.-L., Li, C.-L., Wang, S.-H., Kao, H.-C., Tsai, Y.-M., Wang, H.-Y., Hsieh, C.-L., Chen, P.-J., Chang, S.-Y., Yeh, S.-H.
10.1101/2021.01.27.428541 — Posted: 2021-01-28
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein
DiMuzio, J. M., Heimbach, B. C., Howanski, R. J., Dowling, J. P., Patel, N. B., Henriquez, N., Nicolescu, C., Nath, M., Polley, A., Bingaman, J. L., Smith, T., Harman, B. C., Robinson, M. K., Morin, M. J., Nikitin, P. A.
10.1101/2021.01.27.428534 — Posted: 2021-01-28
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
Shen, X., Tang, H., McDana, C., Wagh, K., Fischer, W., Theiler, J., Yoon, H., Haynes, B. F., Saunders, K. O., Gnanakaran, S., Hengartner, N. W., Pajon, R., Smith, G., Dubovsky, F., Glenn, G. M., Korber, B., Montefiori, D.
10.1101/2021.01.27.428516 — Posted: 2021-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).